Lincy Annet Abraham

Lincy Annet Abraham

Auto-generated profile, based on publicly available information

Lincy Annet Abraham

School of Electronics Engineering, Vellore Institute of Technology, Vellore, India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2025 in IEEE Access
Verified
Journal Article
Open access
LALincy Annet Abraham
Lincy Annet Abraham
GPGopinath Palanisamy
Gopinath Palanisamy
VGVeerapu Goutham
Veerapu Goutham
The extremely low tumor prevalence in the general population makes accurate image-based tumor identification and classification a significant obstacle for medical researchers. Timely therapies and better patient outcomes depend on the capacity to identify cancers in anomalous circumstances. This research seeks to solve the problem by identifying and categorizing brain tumors in difficult cases using deep learning (DL) methods. Hence this paper, Dilated Convolution and YOLOv8 Feature Extraction Network (DC-YOLOv8FEN) is proposed to improve tumor detection accuracy. To begin, the feature extraction network (FEN) is improved with the help of the self shuffle attention (SSA), and the feature map is maximized with the help of vision transformer block. Secondly, a dual feature pyramid network (DFPN) is built to provide more discriminative data for dynamic sparse attention mechanism to extract features from the shallow network and top-down routes to direct the following network modules to fuse features. In addition, the DC-YOLOv8FEN uses a position regression loss function and adds Wise-IoU’s dynamic non-monotonic focus mechanism to make it even better. Based on the experimental results, the proposed method achieved precision of 95.2%, recall rate of 90.5%, accuracy of 99.5% and F1-score of 96.5% which evinces the outstanding performance compared with the existing methods.Radiologists may use this technology for better identification and diagnose brain tumors in real-time medical imaging systems, which improves patient outcomes and reduces diagnostic delays.

1 August 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LALincy Annet Abraham
Lincy Annet Abraham
GPGopinath Palanisamy
Gopinath Palanisamy
GVGoutham Veerapu
Goutham Veerapu
A crucial area of research in the field of medical imaging is that of brain tumor classification, which greatly aids diagnosis and facilitates treatment planning. This paper proposes DenseNet169-LIME-TumorNet, a model based on deep learning and an integrated combination of DenseNet169 with LIME to boost the performance of brain tumor classification and its interpretability. The model was trained and evaluated on the publicly available Brain Tumor MRI Dataset containing 2,870 images spanning three tumor types. Dense169-LIME-TumorNet achieves a classification accuracy of 98.78%, outperforming widely used architectures including Inception V3, ResNet50, MobileNet V2, EfficientNet variants, and other DenseNet configurations. The integration of LIME provides visual explanations that enhance transparency and reliability in clinical decision-making. Furthermore, the model demonstrates minimal computational overhead, enabling faster inference and deployment in resource-constrained clinical environments, thereby highlighting its practical utility for real-time diagnostic support. Work in the future should run towards creating generalization through the adoption of a multi-modal learning approach, hybrid deep learning development, and real-time application development for AI-assisted diagnosis.

18 November 2025 in Artificial Intelligence Review
Verified
Journal Article
Open access
PDF file
LALincy Annet Abraham
Lincy Annet Abraham
GPGopinath Palanisamy
Gopinath Palanisamy
GVGoutham Veerapu
Goutham Veerapu
JNJ. S. Nisha
J. S. Nisha
The analysis and treatment of brain tumors are among the most difficult medical conditions. Brain tumors must be detected accurately and promptly to improve patient outcomes and plan effective treatments. Recently used advanced technologies such as artificial intelligence (AI) and machine learning (ML) have increased interest in applying AI to detect brain tumors. However, concerns have emerged regarding the reliability and transparency of AI models in medical settings, as their decision-making processes are often opaque and difficult to interpret. This research is unique in its focus on explainability in AI-based brain tumor detection, prioritizing confidence, safety, and clinical adoption over mere accuracy. It gives a thorough overview of XAI methodologies, problems, and uses, linking scientific advances to the needs of real-world healthcare. XAI is a sub-section of artificial intelligence that seeks to solve this problem by offering understandable and straightforward and providing explanations for the choices made by AI representations. Applications such as healthcare, where the interpretability of AI models is essential for guaranteeing patient safety and fostering confidence between medical professionals and AI systems, have seen the introduction of XAI-based procedures. This paper reviews recent advancements in XAI-based brain tumor detection, focusing on methods that provide justifications for AI model predictions. The study highlights the advantages of XAI in improving patient outcomes and supporting medical decision-making. The findings reveal that ResNet 18 performed better, with 94% training accuracy, 96.86% testing accuracy, low loss (0.012), and a rapid time $$(\sim 6\text {s})$$ . ResNet 50 was a little slower $$(\sim 13\text {s})$$ but stable, with 92.86% test accuracy. DenseNet121 (Adam W) achieved the highest accuracy at 97.71%, but it was not consistent across all optimizers. ViT-GRU also got 97% accuracy with very little loss (0.008), although it took a long time to compute (around 49 s). On the other hand, VGG models (around 94% test accuracy) and MobileNetV2 (loss up to 6.024) were less reliable, even though they trained faster. Additionally, it explores various opportunities, challenges, and clinical applications. Based on these findings, this research offers a comprehensive analysis of XAI-based brain tumor detection and encourages further investigation in specific areas.